Case studies of expedited review: AZT and L-dopa.
Kaitin
K I
KI
D004059:Diffusion of Innovation; D015507:Drugs, Investigational; D004989:Ethics; D035082:Federal Government; D033161:Government Regulation; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D011358:Product Surveillance, Postmarketing / Q000592:standards*; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration; D015215:Zidovudine / Q000627:therapeutic use*
D015507:Drugs, Investigational; D007980:Levodopa; D015215:Zidovudine